United Kingdom (UK) COVID-19 Molecular Diagnostics Market (2025-2031) | Competitive Landscape, Value, Growth, Outlook, Trends, Analysis, Segmentation, Share, Companies, Forecast, Industry, Size & Revenue

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 United Kingdom (UK) Country Macro Economic Indicators

3.2 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Revenues & Volume, 2021 & 2031F

3.3 United Kingdom (UK) COVID-19 Molecular Diagnostics Market - Industry Life Cycle

3.4 United Kingdom (UK) COVID-19 Molecular Diagnostics Market - Porter's Five Forces

3.5 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Revenues & Volume Share, By Product, 2021 & 2031F

3.6 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Revenues & Volume Share, By Technology, 2021 & 2031F

3.7 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Revenues & Volume Share, By End-user, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing demand for accurate and rapid diagnostic testing for COVID-19 in the UK

4.2.2 Government initiatives and funding to support molecular diagnostics for COVID-19

4.2.3 Technological advancements in molecular diagnostics leading to more efficient testing processes

4.3 Market Restraints

4.3.1 Supply chain disruptions affecting the availability of testing kits and reagents

4.3.2 Regulatory challenges and approvals delaying the introduction of new diagnostic technologies

6.1 United Kingdom (UK) COVID-19 Molecular Diagnostics Market, By Product

6.1.1 Overview and Analysis

6.1.2 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Revenues & Volume, By Product, 2021- 2031F

6.1.3 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Revenues & Volume, By Instruments, 2021- 2031F

6.1.4 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Revenues & Volume, By Reagents & Kits, 2021- 2031F

6.2 United Kingdom (UK) COVID-19 Molecular Diagnostics Market, By Technology

6.2.1 Overview and Analysis

6.2.2 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Revenues & Volume, By PCR, 2021- 2031F

6.2.3 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Revenues & Volume, By Others, 2021- 2031F

6.3 United Kingdom (UK) COVID-19 Molecular Diagnostics Market, By End-user

6.3.1 Overview and Analysis

6.3.2 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Revenues & Volume, By Laboratories, 2021- 2031F

6.3.3 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Revenues & Volume, By Hospitals, 2021- 2031F

6.3.4 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Revenues & Volume, By Diagnostic Centers and Clinics, 2021- 2031F

6.3.5 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Revenues & Volume, By Research Institutes, 2021- 2031F

7.1 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Export to Major Countries

7.2 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Imports from Major Countries

8.1 Turnaround time for COVID-19 test results

8.2 Adoption rate of molecular diagnostic tests by healthcare facilities

8.3 Percentage of population tested for COVID-19 using molecular diagnostics

8.4 Average cost per test for molecular diagnostics in the UK

8.5 Rate of false-negative results in COVID-19 molecular diagnostic tests

9.1 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Opportunity Assessment, By Product, 2021 & 2031F

9.2 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Opportunity Assessment, By Technology, 2021 & 2031F

9.3 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Opportunity Assessment, By End-user, 2021 & 2031F

10.1 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Revenue Share, By Companies, 2024

10.2 United Kingdom (UK) COVID-19 Molecular Diagnostics Market Competitive Benchmarking, By Operating and Technical Parameters